PCA
PAVM icon

Pallas Capital Advisors’s PAVmed PAVM Stock Holding History

Pallas Capital Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-143
Closed -$16.8K – 385
2023
Q3 		$16.8K Buy
143
+36
+34% +$5.58K ﹤0.01% 343
2023
Q2 		$18.8K Hold
107
– – ﹤0.01% 257
2023
Q1 		$23.8K Sell
107
-71
-40% -$14.9K ﹤0.01% 267
2022
Q4 		$36.5K Hold
178
– – ﹤0.01% 262
2022
Q3 		$95K Buy
178
+1
+0.6% +$567 0.01% 247
2022
Q2 		$87K Hold
177
– – 0.01% 222
2022
Q1 		$85K Buy
177
+26
+17% +$19.3K 0.01% 229
2021
Q4 		$107K Sell
151
-45
-23% -$97.8K 0.01% 322
2021
Q3 		$484K Buy
196
+81
+70% +$255K 0.05% 231
2021
Q2 		$362K Buy
115
+48
+72% +$113K 0.05% 231
2021
Q1 		$121K Buy
+67
New +$101K 0.03% 177

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Pallas Capital Advisors's PAVM Position: Q4 2023 in Review

Pallas Capital Advisors sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 143 shares — an estimated $16.8K sold.

Pallas Capital Advisors first reported a position in PAVM in Q1 2021 and held it in 11 quarters. The position peaked at $484K in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Pallas Capital Advisors reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • Pallas Capital Advisors sold 143 PAVmed shares in Q4 2023, an estimated $16.8K.
  • Pallas Capital Advisors first reported a position in PAVmed in Q1 2021 and held it in 11 quarters.
  • Pallas Capital Advisors's PAVmed position peaked at $484K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Pallas Capital Advisors's 13F filing for Q4 2023, filed 22 Jan 2024.